07/01/2025
8:17 PM | Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2025
8:23 PM | Corvus Pharmaceuticals (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP V LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:26 PM | Corvus Pharmaceuticals (Issuer)
Jones William Benton (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
6:00 AM | Corvus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2025
7:49 PM | Corvus Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SCHEDULE 13D/A | |
05/08/2025
4:30 PM | Corvus Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/01/2025
8:20 PM | Corvus Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SCHEDULE 13D/A | |
04/09/2025
4:26 PM | Corvus Pharmaceuticals (Issuer)
van den Broek Richard (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/09/2025
4:26 PM | Corvus Pharmaceuticals (Issuer)
van den Broek Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:21 PM | Corvus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
12:53 PM | Corvus Pharmaceuticals (Subject)
SAMLYN CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G/A | |
01/13/2025
6:30 AM | Corvus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
3:40 PM | Arcara Jeffrey (Reporting)
Corvus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:38 PM | Corvus Pharmaceuticals (Issuer)
MILLER RICHARD A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:39 PM | Corvus Pharmaceuticals (Issuer)
LEA LEIV (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:39 PM | Corvus Pharmaceuticals (Issuer)
Jones William Benton (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
6:30 AM | Corvus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2024
3:11 PM | Corvus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
11:15 PM | Corvus Pharmaceuticals (Filer)
| Form EFFECT | |
08/06/2024
4:31 PM | Corvus Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/01/2024
8:18 PM | Corvus Pharmaceuticals (Subject)
SAMLYN CAPITAL, LLC (Filed by)
| Form SC 13G/A | |
Free CRVS Stock Alerts